Recorded and published daily during #ASGCT2026, Soundbites of the Annual Meeting captures the energy and breadth of the conference through quick-hit conversations, scientific snapshots, attendee perspectives, and highlights from across the field — offering a daily pulse on what’s happening throughout the meeting.

Take a listen from Thursday, May 14, 2026 as we talk with Craig Martin, Founder and CEO of the Orphan Therapeutics Accelerator. Craig discusses the CGTxchange, a new partnership with ASGCT, and how individuals can get involved with the exchange.

This soundbite is hosted by Lynnea Olivarez of the ASGCT Communications Committee.

 

Music: Everything Connected by High Street Music.

Recorded and published daily during #ASGCT2026, Soundbites of the Annual Meeting captures the energy and breadth of the conference through quick-hit conversations, scientific snapshots, attendee perspectives, and highlights from across the field &mdash; offering a daily pulse on what&rsquo;s happening throughout the meeting.
Take a listen from Thursday, May 14, 2026 as we talk with Craig Martin, Founder and CEO of the Orphan Therapeutics Accelerator. Craig discusses the CGTxchange, a new partnership with ASGCT, and how individuals can get involved with the exchange.
This soundbite is hosted by Lynnea Olivarez of the ASGCT Communications Committee.
&nbsp;
Music: Everything Connected by High Street Music.

The American Society of Gene & Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.

The American Society of Gene &amp; Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.

ASGCT Podcast Network

Soundbites Featuring Craig Martin

In this episode, recorded on-site at the ASGCT 2026 Annual Meeting, Molecular Therapy Advances Associate Editor-in-Chief Dr. Dan Stone speaks with Dr. Dan DuBreuil of Sanofi. They break down the science behind a recent paper detailing the development of a secretable frataxin, highlighting its potential to improve treatment efficacy for Friedreich’s ataxia.

Music: 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.au

In this episode, recorded on-site at the ASGCT 2026 Annual Meeting, Molecular Therapy Advances Associate Editor-in-Chief Dr. Dan Stone speaks with Dr. Dan DuBreuil of Sanofi. They break down the science behind a recent paper detailing the development of a secretable frataxin, highlighting its potential to improve treatment efficacy for Friedreich&rsquo;s ataxia.
Music:&nbsp;'Electric Dreams' by Scott Buckley - released under CC-BY 4.0.&nbsp;<a href="https://www.scottbuckley.com.au/">www.scottbuckley.com.au</a>

Development of a secretable frataxin for Friedrich’s ataxia with Dr. Dan DuBreuil

Recorded on site at the ASGCT 2026 Annual Meeting in Boston, this mini-series introduces listeners to ASGCT members and the work driving progress across the cell and gene therapy field. In each episode, members are invited to share their backgrounds, discuss the current state of the field, and reflect on the value of ASGCT membership. This series of brief, engaging conversations will help listeners get to know the people, perspectives, and ideas shaping the ASGCT community.

In this episode, host Ben McLeod of the ASGCT Communications Committee talks with Dr. Mark Deehan of MassGeneral Hospital. Dr. Deehan discusses being a new member of ASGCT and how receiving an ASGCT Career Development Award, funded by the Foundation for Angelman Syndrome Therapeutics (FAST), has advanced his lab work.

Music: 'Origami' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.au

Recorded on site at the ASGCT 2026 Annual Meeting in Boston, this mini-series introduces listeners to ASGCT members and the work driving progress across the cell and gene therapy field. In each episode, members are invited to share their backgrounds, discuss the current state of the field, and reflect on the value of ASGCT membership. This series of brief, engaging conversations will help listeners get to know the people, perspectives, and ideas shaping the ASGCT community.
In this episode, host Ben McLeod of the ASGCT Communications Committee talks with Dr. Mark Deehan of MassGeneral Hospital. Dr. Deehan discusses being a new member of ASGCT and how receiving an ASGCT Career Development Award, funded by the Foundation for Angelman Syndrome Therapeutics (FAST), has advanced his lab work.
Music:&nbsp;'Origami' by Scott Buckley - released under CC-BY 4.0.&nbsp;<a href="https://url.us.m.mimecastprotect.com/s/IkczCERmXJSyRj4iNfxU7G5vB">www.scottbuckley.com.au</a>

Member Minutes: Mark Deehan, PhD

Recorded on site at the ASGCT 2026 Annual Meeting in Boston, this mini-series introduces listeners to ASGCT members and the work driving progress across the cell and gene therapy field. In each episode, members are invited to share their backgrounds, discuss the current state of the field, and reflect on the value of ASGCT membership. This series of brief, engaging conversations will help listeners get to know the people, perspectives, and ideas shaping the ASGCT community.

In this episode, host Ben McLeod of the ASGCT Communications Committee sits down with Chrissy Green, the co-founder and president of Finding Hope for Frizzle (FRRS1L). As a patient advocate, Chrissy discusses how her parent-led organization is working to develop a treatment for FRRS1L. In addition, she shares how the ASGCT Annual Meeting has given her access to individuals and organizations who can help with the development of the treatment.

Music: 'Origami' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.au

Recorded on site at the ASGCT 2026 Annual Meeting in Boston, this mini-series introduces listeners to ASGCT members and the work driving progress across the cell and gene therapy field. In each episode, members are invited to share their backgrounds, discuss the current state of the field, and reflect on the value of ASGCT membership. This series of brief, engaging conversations will help listeners get to know the people, perspectives, and ideas shaping the ASGCT community.
In this episode, host Ben McLeod of the ASGCT Communications Committee sits down with Chrissy Green, the co-founder and president of&nbsp;<a href="https://www.frrs1l.org/" data-auth="NotApplicable" data-linkindex="0">Finding Hope for Frizzle (FRRS1L)</a>. As a patient advocate, Chrissy discusses how her parent-led organization is working to develop a treatment for FRRS1L. In addition, she shares how the ASGCT Annual Meeting has given her access to individuals and organizations who can help with the development of the treatment.
Music:&nbsp;'Origami' by Scott Buckley - released under CC-BY 4.0.&nbsp;<a href="https://url.us.m.mimecastprotect.com/s/IkczCERmXJSyRj4iNfxU7G5vB">www.scottbuckley.com.au</a>

Soundbites Featuring Craig Martin

In 1 playlist(s)

ASGCT Podcast Network

Social links

Follow podcast

Recent clips